Detection of copeptin in peripheral blood of patients with aneurysmal subarachnoid hemorrhage

Critical Care

Volumn 15, Issue 6, 2011, Pages

  Zhu, Xiang Dong ^a   Chen, Jing Sen ^a   Zhou, Feng ^a   Liu, Qi Chang ^a   Chen, Gao ^a   Zhang, Jian Min ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COPEPTIN; NIMODIPINE; PROTEIN; UNCLASSIFIED DRUG; VALPROIC ACID; BIOLOGICAL MARKER; GLYCOPEPTIDE;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BRAIN VASOSPASM; CEREBROSPINAL FLUID DRAINAGE; CONTROLLED STUDY; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLASGOW OUTCOME SCALE; HUMAN; INDUCED HYPOTHERMIA; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SEDATION; SEIZURE; SIDE EFFECT; SUBARACHNOID HEMORRHAGE; BLOOD; CASE CONTROL STUDY; GLASGOW COMA SCALE; MULTIVARIATE ANALYSIS; PROGNOSIS; RISK FACTOR; STATISTICAL MODEL;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLASGOW COMA SCALE; GLYCOPEPTIDES; HUMANS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SUBARACHNOID HEMORRHAGE;

EID: 82255160631     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10575     Document Type: Article

References (42)

1. Morgenthaler NG. Copeptin: a biomarker of cardiovascular and renal function. Congest Heart Fail 2010, 16:S37-44.
2. Morgenthaler NG, Müller B, Struck J, Bergmann A, Redl H, Christ-Crain M. Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. Shock 2007, 28:219-226. 10.1097/SHK.0b013e318033e5da, 17515850.
3. Müller B, Morgenthaler N, Stolz D, Schuetz P, Müller C, Bingisser R, Bergmann A, Tamm M, Christ-Crain M. Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections. Eur J Clin Invest 2007, 37:145-152. 10.1111/j.1365-2362.2007.01762.x, 17217381.
4. Seligman R, Papassotiriou J, Morgenthaler NG, Meisner M, Teixeira PJZ. Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia. Crit Care 2008, 12:R11. 10.1186/cc6780, 2374597, 18252006.
5. Kelly D, Squire IB, Khan SQ, Quinn P, Struck J, Morgenthaler NG, Davies JE, Ng LL. C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction. J Card Fail 2008, 14:739-745. 10.1016/j.cardfail.2008.07.231, 18995178.
6. Stoiser B, Mörtl D, Hülsmann M, Berger R, Struck J, Morgenthaler NG, Bergmann A, Pacher R. Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure. Eur J Clin Invest 2006, 36:771-778. 10.1111/j.1365-2362.2006.01724.x, 17032344.
7. Voors AA, von Haehling S, Anker SD, Hillege HL, Struck J, Hartmann O, Bergmann A, Squire I, van Veldhuisen DJ, Dickstein K, . OPTIMAAL Investigators C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study. Eur Heart J 2009, 30:1187-1194. 10.1093/eurheartj/ehp098, 19346228, OPTIMAAL Investigators.
8. Katan M, Fluri F, Morgenthaler NG, Schuetz P, Zweifel C, Bingisser R, Müller K, Meckel S, Gass A, Kappos L, Steck AJ, Engelter ST, Müller B, Christ-Crain M. Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Ann Neurol 2009, 66:799-808.
9. Urwyler SA, Schuetz P, Fluri F, Morgenthaler NG, Zweifel C, Bergmann A, Bingisser R, Kappos L, Steck A, Engelter S, Müller B, Christ-Crain M, Katan M. Prognostic value of copeptin: one-year outcome in patients with acute stroke. Stroke 2010, 41:1564-1567. 10.1161/STROKEAHA.110.584649, 20508186.
10. Zweifel C, Katan M, Schuetz P, Siegemund M, Morgenthaler NG, Merlo A, Mueller B, Christ-Crain M. Copeptin is associated with mortality and outcome in patients with acute intracerebral hemorrhage. BMC Neurol 2010, 10:34. 10.1186/1471-2377-10-34, 2889932, 20504314.
11. Kleindienst A, Brabant G, Morgenthaler NG, Dixit KC, Parsch H, Buchfelder M. Following brain trauma, copeptin, a stable peptide derived from the AVP precusor, does not reflect osmoregulation but correlates with injury severity. Acta Neurochir Suppl 2010, 106:221-224. 10.1007/978-3-211-98811-4_41, 19812953.
12. Dong XQ, Huang M, Yang SB, Yu WH, Zhang ZY. Copeptin is associated with mortality in patients with traumatic brain injury. J Trauma 2011,
13. Dong XQ, Huang M, Yu WH, Zhang ZY, Zhu Q, Che ZH, Du Q, Wang H. Change in plasma copeptin level after acute spontaneous basal ganglia hemorrhage. Peptides 2011, 32:253-257. 10.1016/j.peptides.2010.11.021, 21126545.
14. Drake C. Report of World Federation of Neurological Surgeons Committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg 1988, 68:985-986.
15. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980, 6:1-9. 10.1227/00006123-198001000-00001, 7354892.
16. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975, 1:480-484.
17. Katan M, Müller B, Christ-Crain M. Copeptin: a new and promising diagnostic and prognostic marker. Crit Care 2008, 12:117. 10.1186/cc6799, 2447549, 18355399.
18. Rosen DS, Macdonald RL. Grading of subarachnoid hemorrhage: modification of the world World Federation of Neurosurgical Societies scale on the basis of data for a large series of patients. Neurosurgery 2004, 54:566-575. 10.1227/01.NEU.0000108862.32404.A5, 15028129.
19. Juvela S, Siironen J. D-dimer as an independent predictor for poor outcome after aneurysmal subarachnoid hemorrhage. Stroke 2006, 37:1451-1456. 10.1161/01.STR.0000221710.55467.33, 16690901.
20. Fountas KN, Tasiou A, Kapsalaki EZ, Paterakis KN, Grigorian AA, Lee GP, Robinson JS. Serum and cerebrospinal fluid C-reactive protein levels as predictors of vasospasm in aneurysmal subarachnoid hemorrhage. Neurosurg Focus 2009, 26:E22. 10.3171/2009.2.FOCUS08311, 19409001.
21. Dumont AS, Crowley RW, Monteith SJ, Ilodigwe D, Kassell NF, Mayer S, Ruefenacht D, Weidauer S, Pasqualin A, Macdonald RL. Endovascular treatment or neurosurgical clipping of ruptured intracranial aneurysms: effect on angiographic vasospasm, delayed ischemic neurological deficit, cerebral infarction, and clinical outcome. Stroke 2010, 41:2519-2524. 10.1161/STROKEAHA.110.579383, 20813994.
22. Itoi K, Jiang YQ, Iwasaki Y, Watson SJ. Regulatory mechanisms of corticotrophin - releasing hormone and vasopressin gene expression in the hypothalamus. J Neuroendocrinol 2004, 16:348-355. 10.1111/j.0953-8194.2004.01172.x, 15089973.
23. Asfar P, Hauser B, Radermacher P, Matejovic M. Catecholamines and vasopressin during critical illness. Crit Care Clin 2006, 22:131-149. 10.1016/j.ccc.2005.08.007, 16399024.
24. Itoi K, Seasholtz AF, Watson SJ. Cellular and extracellular regulatory mechanisms of hypothalamic corticotropin-releasing hormone neurons. Endocr J 1998, 45:13-33. 10.1507/endocrj.45.13, 9625443.
25. Katan M, Morgenthaler N, Widmer I, Puder JJ, Konig C, Muller B, Christ-Crain M. Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level. Neuro Endocrinol Lett 2008, 29:341-346.
26. Struck J, Morgenthaler NG, Bergmann A. Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients. Peptides 2005, 26:2500-2504. 10.1016/j.peptides.2005.04.019, 15922490.
27. Vakili A, Kataoka H, Plesnila N. Role of arginine vasopressin V1 and V2 receptors for brain damage after transient focal cerebral ischemia. J Cereb Blood Flow Metab 2005, 25:1012-1019. 10.1038/sj.jcbfm.9600097, 15744246.
28. Molnar AH, Varga C, Berko A, Rojik I, Parducz A, Laszlo F, Laszlo FA. Inhibitory effect of vasopressin receptor antagonist OPC-31260 on experimental brain oedema induced by global cerebral ischaemia. Acta neurochirurgica 2008, 150:265-271. 10.1007/s00701-007-1400-1, 18288441.
29. Trabold R, Krieg S, Scholler K, Plesnila N. Role of vasopressin V(1a) and V2 receptors for the development of secondary brain damage after traumatic brain injury in mice. Journal of neurotrauma 2008, 25:1459-1465. 10.1089/neu.2008.0597, 19118456.
30. Xu M, Su W, Huang WD, Lu YQ, Xu QP, Chen ZJ. Effect of AVP on brain edema following traumatic brain injury. Chinese journal of traumatology 2007, 10:90-93.
31. Sobey CG, Faraci FM. Subarachnoid haemorrhage: What happens to the cerebral arteries?. Clin Exp Pharmacol Physiol 1998, 25:867-876. 10.1111/j.1440-1681.1998.tb02337.x, 9807657.
32. Cook DA. Mechanisms of cerebral vasospasm in subarachnoid haemorrhage. Pharmacol Ther 1995, 66:259-284. 10.1016/0163-7258(94)00080-M, 7667398.
33. Cach R, Durboraw C, Smock T, Albeck D. Microvascular spasm is mediated by vasopressin fibers in the rat hippocampal slice. Brain Res 1989, 483:221-225. 10.1016/0006-8993(89)90166-2, 2706515.
34. Delgado TJ, Abdul-Rahman Arbab M, Warberg J, Svendgaard NA. The role of vasopressin in acute cerebral vasospasm. J Neurosurg 1988, 68:266-273. 10.3171/jns.1988.68.2.0266, 3339443.
35. Doczi T, Laszlo FA, Szerdahelyi P, Joo P. Involvement of vasopressin in brain edema formation: Further evidence obtained from the Brattleboro diabetes insipidus rat with experimental subarachnoid hemorrhage. Neurosurgery 1984, 14:436-441. 10.1227/00006123-198404000-00008, 6728146.
36. Shuaib A, Wang CX, Yang T, Noor R. Effects of nonpeptide V1 vasopressin receptor antagonist SR-49059 on infarction volume and recovery of function in a focal embolic stroke model. Stroke 2002, 33:3033-3037. 10.1161/01.STR.0000039405.31526.06, 12468809.
37. Fernández N, Martínez MA, García-Villalón AL, Monge L, Diéguez G. Cerebral vasoconstriction produced by vasopressin in conscious goats. Role of vasopressin V1 and V2 receptors and nitric oxide. Br J Pharmacol 2001, 132:1837-1844. 10.1038/sj.bjp.0704034, 1572748, 11309256.
38. Garcia-Villalon AL, Garcia JL, Fernandez N, Monge L, Gomez B, Dieguez G. Regional differences in the arterial response to vasopressin: Role of endothelial nitric oxide. Br J Pharmacol 1996, 118:1848-1854. 1909857, 8842453.
39. Katori E, Ohta T, Nakazato Y, Ito S. Vasopressin-induced contraction in the basilar artery in vitro. Eur J Pharmacol 2001, 416:113-121. 10.1016/S0014-2999(01)00781-6, 11282120.
40. Kurahashi K, Wang A, Koshino Y, Nishihashi T. Arginine vasopressin-induced contraction of rat basilar artery: Involvement of endothelium, reactive oxygen species, 5-lipoxygenase and leukotriene B4. Jpn J Pharmacol 2002, 88:267.
41. Tsuji T, Cook DA. Vasoconstrictor mechanism of neuropeptides augmented after endothelial removal in isolated, perfused canine basilar arteries. Neurol Res 1995, 17:193-200.
42. Delgado TJ, Brismar J, Svendgaard NA. Subarachnoid haemorrhage in the rat: Angiography and fluorescence microscopy of the major cerebral arteries. Stroke 1985, 16:595-602. 10.1161/01.STR.16.4.595, 4024174.